Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hepato Cellular Carcinoma × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 237 Neoplasms 222 Carcinoma, Non-Small-Cell Lung 211 Prostatic Neoplasms 141 Colorectal Neoplasms 126 Lung Neoplasms 121 Neoplasm Metastasis 116 Leukemia, Myeloid, Acute 99 Ovarian Neoplasms 97 Multiple Myeloma 93 Pancreatic Neoplasms 76 Recurrence 73 Squamous Cell Carcinoma of Head and Neck 66 Endometrial Neoplasms 62 Carcinoma, Hepatocellular 59 Stomach Neoplasms 58 Melanoma 55 Carcinoma, Renal Cell 55 Brain Neoplasms 55 Triple Negative Breast Neoplasms 53 Urinary Bladder Neoplasms 52 Leukemia, Lymphocytic, Chronic, B-Cell 49 Hematologic Neoplasms 49 Lymphoma, Non-Hodgkin 48 Lymphoma, Large B-Cell, Diffuse 47 Small Cell Lung Carcinoma 46 Precursor Cell Lymphoblastic Leukemia-Lymphoma 44 Head and Neck Neoplasms 43 Glioblastoma 41 Sarcoma 39

Interventions

tremelimumab 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07489976 2026-03-27

IIT2025-03-YANG-LIFT-HCC

Cedars-Sinai Medical Center

Phase 2 Recruiting

Hepato Cellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡